Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hospital General Universitario Gregorio Marañon | OTHER |
| Hospital Universitario 12 de Octubre | OTHER |
| Puerta de Hierro University Hospital | OTHER |
Not provided
Not provided
Not provided
The protocol aims to evaluate the efficacy of the radial ablation technique of the maintenance mechanisms in persistent atrial fibrillation compared to the isolation of the pulmonary veins evaluating the atrial fibrillation burden during one year follow-up.
Atrial fibrillation is the most common arrhythmia in clinical practice, and its treatment still remains suboptimal. Electrical isolation of the pulmonary veins with radiofrequency ablation or cryoablation is the standard therapy when antiarrhythmic drugs or electrical cardioversion is not successful. However, recurrence after catheter ablation worsens in persistent and permanent atrial fibrillation patients. Recently, rotational activity electrogram patterns of self-sustained electrical activity found in the atria have been proposed as the responsible mechanism for the maintenance of atrial fibrillation. The investigators devised a controlled, multicentric, prospective, not blinded, and randomized clinical trial with the aim of comparing pulmonary vein catheter ablation versus radial ablation of sites exhibiting rotational activity in patients with persistent atrial fibrillation. Radial ablation consists of the ablation of the rotational activity sites and an additional ablation line connecting the rotation site with the circumferential ablation line of the pulmonary veins.
Besides, subanalysis ARTIST-Gender and ARTIST-HF will be performed. ARTIST-Gender will compare the same outcomes and analysis of the patient cohort but according to the gender of the patient, and ARTIST-HF will sub-divide the analysis with respect to heart failure present in the enrolled patients' cohort.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control arm. Pulmonary vein isolation | Active Comparator | Pulmonary vein isolation with ablation. |
|
| Treatment arm. Radial ablation | Experimental | Pulmonary vein isolation plus radial ablation of rotational activity sites. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pulmonary vein electrical isolation | Procedure | Electrical isolation of the pulmonary veins from the left atrium with cryoablation therapy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Atrial fibrillation burden (1 year) | Atrial fibrillation burden. Holter monitoring at 4, 8 and 12 months. Time to first atrial fibrillation episode. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | Patients will be followed up during one year, regardless of reaching or not the primary endpoint. |
| Atrial flutter burden (1 year) | Atrial flutter burden. Holter monitoring at 4, 8 and 12 months. Time to first atrial flutter episode. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | Patients will be followed up during one year, regardless of reaching or not the primary endpoint. |
| Atrial tachycardia burden (1 year) | Atrial tachycardia burden. Holter monitoring at 4, 8 and 12 months. Time to first atrial tachycardia episode. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | Patients will be followed up during one year, regardless of reaching or not the primary endpoint. |
| Measure | Description | Time Frame |
|---|---|---|
| Occurrence of severe complication of the ablation procedure | Occurrence of severe complications of the ablation procedure Will be identified through review of patient clinical reports. One week post-procedural complications included. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Angel Arenal, MD, PhD | Hospital General Universitario Gregorio Marañón | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital General Universitario Gregorio Marañon | Madrid | Madrid | 28009 | Spain | ||
| Hospital Universitario 12 de Octubre |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
Control and treatment arms. Control group refers to pulmonary vein isolation ablation. Treatment group refers to pulmonary vein isolation plus radial ablation of rotational activity sites.
Not provided
Not provided
Not provided
Not provided
|
| Radial ablation | Procedure | Electrical isolation of the pulmonary veins from the left atrium plus radial ablation of rotational activity sites with radiofrequency ablation. |
|
| Overall clinical procedure, radiofrequency and fluoroscopy durations |
Total time registered during the clinical procedure. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. |
| 2 years |
| Accute procedural success rate | Accute procedural success as the percentage of episodes that revert to sinus flutter or sinus rhythm during the ablation procedure. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 2 years |
| Occurrence of hospitalization for cardiovascular cause | Unforeseen hospitalization for cardiovascular cause requiring overnight hospital stay during the 12 month follow-up. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 1 year |
| Cerebrovascular accident unforeseen hospitalization | Unforeseen hospitalization due to cerebrovascular accident (CVA) requiring overnight hospital stay during the 12 month follow-up. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 1 year |
| Heart failure unforeseen hospitalization | Unforeseen hospitalization due to new diagnosis for heart failure requiring overnight hospital stay during the 12 month follow-up. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 1 year |
| Functional class worsening unforeseen hospitalization | Unforeseen hospitalization due to functional class worsening due to heart failure requiring overnight hospital stay during the 12 month follow-up. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 1 year |
| Final functional class at the end of the study | Final functional class at the end of the study. New York Heart Association (NYHA) classification. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 2 years |
| Total and cardiac mortality | Total and cardiac mortality Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 2 years |
| Quality of life measured with the The Short Form (36) Health Survey | Quality of life is measured with the The Short Form (36) Health Survey at pre-specified study follow-up visits (4, 8, 12 months). The short-form (36) health survey consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. Extended analyses by gender and heart failure presence in subanalyses ARTIST-Gender and ARTIST-HF. | 1 year |
| Madrid |
| Madrid |
| 28041 |
| Spain |
| Hospital Universitario Puerta de Hierro | Majadahonda | Madrid | 28222 | Spain |
| D013568 |
| Pathological Conditions, Signs and Symptoms |